Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 2.9 Announcement

20 Jan 2023 07:00

RNS Number : 3277N
Impellam Group plc
20 January 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

20 January 2023

Impellam Group plc

("Impellam" or the "Company")

Rule 2.9 Announcement

Impellam Group PLC, the largest staffing business in the UK and 8th largest MSP worldwide, announced on 12 April 2022 that it had entered into an offer period.

As announced earlier today, on 19 January 2023 Canaccord Genuity Limited, the Company's Nominated Adviser and Broker, repurchased 3200 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") on behalf of the Company, pursuant to the Share Purchase Plan announced on 8 July 2022. The Ordinary Shares have been cancelled.

Following cancellation of the Ordinary Shares purchased, the number of Ordinary Shares in issue and admitted to trading on AIM will be reduced to 45,045,879. This figure of 45,045,879 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The Ordinary Shares are relevant securities of Impellam Group plc for the purposes of Rule 8 of The City Code on Takeovers and Mergers (the "Code"). In accordance with Rule 2.9 of the Code, Impellam confirms that it has in issue 45,045,879 Ordinary Shares and admitted to trading on the AIM Market of the London Stock Exchange. The Company has no Ordinary Shares held in Treasury. The International Securities Identification Number for Impellam Ordinary Shares is GB00B8HWGJ55.

 

Enquiries:

Impellam Group plc

Julia Robertson, Chief Executive Officer

 

01582 692 658

Canaccord Genuity Ltd (Nomad and Sole Broker)

Bobbie Hilliam

Emma Gabriel

Thomas Diehl

 

020 7523 8150

 

 

Miscellaneous

Canaccord Genuity Limited which is regulated in the United Kingdom by The Financial Conduct Authority is acting for the Company in relation to the matters described in this announcement and is not advising any other person, and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to customers of Canaccord Genuity Limited or for providing advice in relation to the matters described in this announcement.

 

Note to Editors:

Our Managed Services businesses are enabled by talent-focused Specialist Staffing brands with deep heritages, vertical sector expertise and loyal candidate networks. Clients across the world trust us to deliver Managed Services and Specialist Staffing in the UK, North America, Asia Pacific and Europe.

 

Working with them are 2,900 Impellam people, bringing a wealth of expertise through our 13 market-leading brands across 70 locations. Every year, we connect carefully chosen candidates with good work at all levels. They include technology and digital specialists, scientists, clinical experts, engineers, nurses, doctors, lawyers, teachers, receptionists, drivers, chefs, administrators, warehouse and call centre operatives.

 

Underpinning everything we do is our Virtuoso strategy which recognises it is our people who make the difference. Virtuosos make and deliver on promises, and grow with their customers through sector, service or international expansion which ensures there is never a need for a customer or candidate to leave Impellam. Impellam is the largest Global Talent Acquisition and Managed Workforce Solutions provider in the UK, and 8th1 in the world.

 

For more information about Impellam Group please visit: www.impellam.com

 

1 By SUM (confirmed by Staffing Industry Analysts). Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2020 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTEAPFNFEDDEFA
Date   Source Headline
17th Feb 20239:29 amRNSForm 8.5 (EPT/RI)
16th Feb 20233:00 pmRNSForm 8.3 - Impellam Group plc
16th Feb 202310:13 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
15th Feb 202310:44 amRNSForm 8.5 (EPT/RI)
15th Feb 20237:01 amRNSRule 2.9 Announcement
15th Feb 20237:00 amRNSTransaction in Own Shares
14th Feb 202310:00 amRNSTransaction in Own Shares
14th Feb 202310:00 amRNSRule 2.9 Announcement
14th Feb 20239:14 amRNSForm 8.5 (EPT/RI)
10th Feb 202310:51 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
10th Feb 20237:01 amRNSRule 2.9 Announcement
10th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 202311:09 amRNSForm 8.5 (EPT/RI)
9th Feb 20239:16 amRNSRule 2.9 Announcement
9th Feb 20239:15 amRNSTransaction in Own Shares
8th Feb 20239:30 amRNSRule 2.9 Announcement
8th Feb 20239:30 amRNSTransaction in Own Shares
8th Feb 20237:17 amRNSForm 8.5 (EPT/RI)
6th Feb 20232:16 pmRNSRule 2.9 Announcement
6th Feb 20232:15 pmRNSTransaction in Own Shares
6th Feb 202311:32 amRNSRule 2.9 Announcement
6th Feb 202311:30 amRNSTransaction in Own Shares
6th Feb 202310:02 amRNSForm 8.5 (EPT/RI)
2nd Feb 202311:24 amRNSForm 8.5 (EPT/RI)
31st Jan 202310:41 amRNSForm 8.5 (EPT/RI)
31st Jan 20237:00 amRNSRule 2.9 Announcement
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSDisposal and Trading Update
20th Jan 202311:08 amRNSForm 8.5 (EPT/RI)
20th Jan 20237:00 amRNSRule 2.9 Announcement
20th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 202310:54 amRNSForm 8.3 - Impellam Group plc
18th Jan 202310:00 amRNSTransaction in Own Shares
18th Jan 202310:00 amRNSRule 2.9 Announcement
18th Jan 20238:59 amRNSForm 8.5 (EPT/RI)
16th Jan 202311:11 amRNSForm 8.3 - Impellam Group plc
16th Jan 202311:00 amRNSRule 2.9 Announcement
16th Jan 202311:00 amRNSTransaction in Own Shares
16th Jan 202310:40 amRNSForm 8.5 (EPT/RI)
13th Jan 202311:28 amRNSForm 8.5 (EPT/RI)
13th Jan 202310:00 amRNSRule 2.9 Announcement
13th Jan 202310:00 amRNSTransaction in Own Shares
12th Jan 202310:47 amRNSForm 8.3 - Impellam Group PLC
12th Jan 20238:57 amRNSForm 8.5 (EPT/RI)
12th Jan 20237:00 amRNSRule 2.9 Announcement
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 202310:04 amRNSForm 8.5 (EPT/RI)
10th Jan 202312:25 pmRNSForm 8.3 - Impellam Group PLC
10th Jan 20239:25 amRNSForm 8.5 (EPT/RI)
9th Jan 202311:46 amRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.